GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SCL Science Inc (XKRX:246960) » Definitions » Change In Receivables

SCL Science (XKRX:246960) Change In Receivables : ₩-2,362 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is SCL Science Change In Receivables?

SCL Science's change in receivables for the quarter that ended in Mar. 2025 was ₩-1,594 Mil. It means SCL Science's Accounts Receivable increased by ₩1,594 Mil from Dec. 2024 to Mar. 2025 .

SCL Science's change in receivables for the fiscal year that ended in Dec. 2024 was ₩-1,453 Mil. It means SCL Science's Accounts Receivable increased by ₩1,453 Mil from Dec. 2023 to Dec. 2024 .

SCL Science's Accounts Receivable for the quarter that ended in Mar. 2025 was ₩5,764 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. SCL Science's Days Sales Outstanding for the three months ended in Mar. 2025 was 231.96.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. SCL Science's liquidation value for the three months ended in Mar. 2025 was ₩-14,859 Mil.


SCL Science Change In Receivables Historical Data

The historical data trend for SCL Science's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCL Science Change In Receivables Chart

SCL Science Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.03 -14.63 -4.09 -496.99 -1,452.57

SCL Science Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -684.82 -564.73 93.90 -296.92 -1,594.13

SCL Science Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,362 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SCL Science  (XKRX:246960) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

SCL Science's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=5763.552/2267.289*91
=231.96

2. In Ben Graham's calculation of liquidation value, SCL Science's accounts receivable are only considered to be worth 75% of book value:

SCL Science's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=11367.554-31157.754+0.75 * 5763.552+0.5 * 1216.073
=-14,859

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SCL Science Change In Receivables Related Terms

Thank you for viewing the detailed overview of SCL Science's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


SCL Science Business Description

Traded in Other Exchanges
N/A
Address
206 to 1210, 25 Seonyu-ro 13-gil, Yeongdeungpo-gu, Mullae-dong 6-ga, Ace High Tech City 2, Seoul, KOR, 07282
SCL Science Inc formerly InnoTherapy Inc is a South-Korea based medical device company. It has developed a technology to control physical property of bio-inspired by the adhesive properties of living organisms. The products offered by the company include InnoSEAL, EndoSil and GellySil among others.

SCL Science Headlines

No Headlines